- Home
- PACS vs MIR Comparison
PACS vs MIR Comparison
Compare PACS & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PACS | MIR |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.7B |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | PACS | MIR |
|---|---|---|
| Price | $39.07 | $27.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $39.67 | $28.29 |
| AVG Volume (30 Days) | 1.2M | ★ 2.2M |
| Earning Date | 03-13-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 176.35 | N/A |
| EPS | ★ 1.04 | 0.10 |
| Revenue | ★ $5,138,841,000.00 | $902,300,000.00 |
| Revenue This Year | $32.53 | $8.75 |
| Revenue Next Year | $7.71 | $23.17 |
| P/E Ratio | ★ $37.98 | $258.61 |
| Revenue Growth | ★ 37.58 | 7.82 |
| 52 Week Low | $7.50 | $12.00 |
| 52 Week High | $43.08 | $30.28 |
Technical Indicators
Market Signals| Indicator | PACS | MIR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 65.86 |
| Support Level | N/A | $26.01 |
| Resistance Level | N/A | $27.21 |
| Average True Range (ATR) | 0.00 | 0.86 |
| MACD | 0.00 | 0.38 |
| Stochastic Oscillator | 0.00 | 99.51 |
Price Performance
Historical ComparisonAbout PACS PACS Group Inc.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.